-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qnnwchu7HQlXzVwjKCMcznVMDtBKzKfafqW8gKON5LY2w0evuuTcIe3yPyzmGRNk BNNB9KeTW4BeHLRsvQCuaw== 0000903112-99-001232.txt : 19991104 0000903112-99-001232.hdr.sgml : 19991104 ACCESSION NUMBER: 0000903112-99-001232 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19991103 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MARVEL ENTERPRISES INC CENTRAL INDEX KEY: 0000933730 STANDARD INDUSTRIAL CLASSIFICATION: DOLLS & STUFFED TOYS [3942] IRS NUMBER: 133711775 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-47191 FILM NUMBER: 99740366 BUSINESS ADDRESS: STREET 1: 387 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 2126960808 MAIL ADDRESS: STREET 1: 685 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: TOY BIZ INC DATE OF NAME CHANGE: 19941213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZIB INC ET AL CENTRAL INDEX KEY: 0001008178 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: PO BOX 1028 CITY: LAKE WORTH STATE: FL ZIP: 33460-1028 MAIL ADDRESS: STREET 1: PO BOX 1028 CITY: LAKE WORTH STATE: FL ZIP: 33460-1028 SC 13D/A 1 SCHEDULE 13D - AMENDMENT NO. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Marvel Enterprises, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) 8% Cumulative Convertible Exchangeable Preferred Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 57383M-20-7 - -------------------------------------------------------------------------------- (CUSIP Number) John N. Turitzin Battle Fowler LLP 75 East 55th Street New York, New York 10022 (212) 856-6873 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 2, 1999 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. 887758.2 - ----------------------- CUSIP No. 57383M-20-7 SCHEDULE 13D - ----------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Biobright Corporation - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) / / - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER None ----------------------------------------------- 8 SHARED VOTING POWER 10,815,150 (See Item 5) ----------------------------------------------- 9 SOLE DISPOSITIVE POWER 250,000 ----------------------------------------------- 10 SHARED DISPOSITIVE POWER None - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,815,150 (See Item 5) - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 59.1% - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - ------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. 887758.2 - ----------------------- CUSIP No. 57383M-20-7 SCHEDULE 13D - ----------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Classic Heroes, Inc. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER None ----------------------------------------------- 8 SHARED VOTING POWER 10,815,150 (See Item 5) ----------------------------------------------- 9 SOLE DISPOSITIVE POWER 250,000 ----------------------------------------------- 10 SHARED DISPOSITIVE POWER None - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,815,150 (See Item 5) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 59.1% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. 887758.2 - ------------------------- CUSIP No. 57383M-20-7 SCHEDULE 13D - ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Isaac Perlmutter T.A. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) / / - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Florida - ------------------------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER None ----------------------------------------------- 8 SHARED VOTING POWER 10,815,150 (See Item 5) ----------------------------------------------- 9 SOLE DISPOSITIVE POWER 314,704 ----------------------------------------------- 10 SHARED DISPOSITIVE POWER None - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,815,150 (See Item 5) - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 59.1% - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* OO - ------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. 887758.2 - ------------------------- CUSIP No. 57383M-20-7 SCHEDULE 13D - ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Isaac Perlmutter - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* PF - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) / / - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. - ------------------------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER None ----------------------------------------------- 8 SHARED VOTING POWER 10,815,150 (See Item 5) ----------------------------------------------- 9 SOLE DISPOSITIVE POWER 4,595,479 ----------------------------------------------- 10 SHARED DISPOSITIVE POWER None - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 10,815,150 (See Item 5) - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 59.1% - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - ------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. 887758.2 - ------------------------ CUSIP No. 57383M-20-7 SCHEDULE 13D - ------------------------ This Amendment No. 3 to Schedule 13D amends and supplements the original Schedule 13D and Amendments No. 1 and No. 2 thereto, dated October 13, 1998, October 20, 1998 and December 21, 1998, respectively, which were filed with the Securities and Exchange Commission (the "Commission") on October 13, 1998, October 20, 1998 and December 22, 1998, respectively, on behalf of (1) Zib Inc., a Delaware corporation, (2) the Isaac Perlmutter T.A., a Florida trust, (3) Object Trading Corp., a Delaware corporation, (4) the Laura & Isaac Perlmutter Foundation Inc., a Florida not-for-profit corporation, and (5) Isaac Perlmutter with respect to the ownership of 8% Preferred Stock of Marvel Enterprises, Inc. (the "Company"). Each capitalized term not defined in this amendment has the same meaning here as in the original 13D. Item 2. Identity and Background. Item 2 is hereby amended and supplemented by adding the following: This Statement is also filed by Isaac Perlmutter T.A., a Florida trust (the "Trust"), Biobright Corporation ("Biobright"), a Delaware corporation whose sole stockholder is Mr. Perlmutter, and Classic Heroes, Inc. ("Classic Heroes"), a Delaware corporation whose sole stockholder is Mr. Perlmutter. Mr. Perlmutter is a trustee and the sole beneficiary of the Trust, and may revoke the Trust at any time. The previously defined term "Reporting Persons" shall hereinafter include the Trust, Biobright and Classic Heroes, and the phrase "neither of the Reporting Persons" shall accordingly be changed to "none of the Reporting Persons." The business address and the principal executive office of the Trust is P.O. Box 1028, Lake Worth, Florida 33460. The Trust's principal business is investment. The business address and the principal executive office of Biobright is P.O. Box 1028, Lake Worth, Florida 33460. Biobright's principal business is the manufacturing and distribution of toothbrushes. The business address and the principal executive office of Classic Heroes is 685 Third Avenue, New York, New York 10017. Classic Heroes' principal business is the manufacture and distribution of apparel. Item 3. Source and Amount of Funds or Other Consideration. Item 3 is hereby amended and supplemented by adding the following: The Trust, Biobright and Classic Heroes obtained the funds to make their respective purchases from capital contributions by Mr. Perlmutter. Mr. Perlmutter's personal funds were used to make those capital contributions. Item 5. Interest in Securities of the Issuer. Item 5 is hereby amended and supplemented by adding the following: (a) As of November 3, 1999, the Reporting Persons may be deemed to beneficially own, to the best of their knowledge, an aggregate of 10,815,150 shares of 8% Preferred Stock, representing 887758.2 - ------------------------ CUSIP No. 57383M-20-7 SCHEDULE 13D - ------------------------ approximately 51.9% of the outstanding shares of 8% Preferred Stock. Biobright and Classic Heroes are each the direct owners of 250,000 shares of 8% Preferred Stock, or 1.4% of the outstanding shares of 8% Preferred Stock. The Trust is the direct owner of 314,704 shares of 8% Preferred Stock, or 1.7% of the outstanding shares of 8% Preferred Stock. (b) Mr. Perlmutter may be deemed to possess the power to vote and dispose of the shares of 8% Preferred Stock owned by the Trust, Biobright and Classic Heroes. The Trust, Biobright and Classic Heroes have the power to vote and dispose of the shares of the 8% Preferred Stock they respectively own. (c) On November 2, 1999, the Trust, Biobright and Classic Heroes purchased an aggregate of 814,704 shares of 8% Preferred Stock, in each case at a price of $6 3/8 per share, in a privately negotiated transaction as follows: Biobright Corporation 250,000 shares, Classic Heroes, Inc. 250,000 shares and the Trust 314,704 shares. Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. Item 6 is hereby amended and supplemented by adding the following: The 814,704 shares of 8% Preferred Stock purchased by the Trust, Biobright and Classic Heroes on November 2, 1999 were purchased from Dickstein & Co., L.P., Dickstein International Limited and Elyssa Dickstein, each of whom is a signatory to the Stockholders' Agreement. Those shares, in the hands of the Trust, Biobright and Classic Heroes, will continue to be subject to the Stockholders' Agreement. In connection with the November 2, 1999 purchase of 814,704 shares of 8% Preferred Stock, the buyers and sellers entered into an agreement (the "Letter Agreement") pursuant to which, among other things, effective upon the sale of the shares, each of the Dickstein Entities signatory to the Letter Agreement and Mark Dickstein, as Dickstein Designator (as defined in the Stockholders' Agreement), (i) waive their rights under the Stockholders' Agreement to have a Dickstein Designee (as defined in the Stockholders' Agreement) nominated and/or elected as a director of the Company and (ii) relinquish all other rights under the Stockholders' Agreement. A copy of the Letter Agreement is annexed hereto as Exhibit 4. Under the Stockholders' Agreement, the Dickstein Entities had the right to designate one individual to serve as a director of the Company. The Reporting Persons anticipate that Peter Cuneo, the Company's President and Chief Executive Officer, will be appointed to fill the board seat previously held by a designee of the Dickstein Entities. Item 7. Material to Be Filed as Exhibits. Item 7 is hereby amended and supplemented by adding the following: 4 -- Letter Agreement dated November 2, 1999 in the form of letter from Classic Heroes, Inc., Biobright Corporation, and Isaac Perlmutter T.A. to Mark Dickstein, Dickstein & Co., L.P., Dickstein Focus Fund L.P., Dickstein International Limited, Elyssa Dickstein, Jeffrey Schwarz and Alan Cooper as Trustees U/T/A/D 12/27/88, Mark Dickstein, Grantor, and Mark Dickstein and Elyssa Dickstein, as trustees of the Mark and Elyssa Dickstein Foundation. 887758.2 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: November 3, 1999 BIOBRIGHT CORPORATION By: /s/ Isaac Perlmutter -------------------------- Name: Isaac Perlmutter Title: President CLASSIC HEROES, INC. By: /s/ Isaac Perlmutter -------------------------- Name: Isaac Perlmutter Title: President ISAAC PERLMUTTER T.A. By: /s/ Isaac Perlmutter -------------------------- Isaac Perlmutter, Trustee 887758.2 EX-4 2 LETTER AGREEMENT DATED NOVEMBER 2, 1999 CLASSIC HEROES, INC. BIOBRIGHT CORPORATION ISAAC PERLMUTTER T.A. P.O. Box 1028 Lake Worth, Florida 33460-1028 November 2, 1999 Mark Dickstein Dickstein & Co., L.P. Dickstein Focus Fund L.P. Dickstein International Limited Elyssa Dickstein, Jeffrey Schwarz and Alan Cooper as Trustees U/T/A/D 12/27/88, Mark Dickstein, Grantor Mark Dickstein and Elyssa Dickstein, as trustees of the Mark and Elyssa Dickstein Foundation c/o Dickstein Partners Inc. 660 Madison Avenue, 16th Floor Ladies and Gentlemen: We have discussed with Dickstein & Co., L.P., Dickstein International Limited and Elyssa Dickstein (the "Sellers") our proposed purchase from the Sellers of an aggregate of 814,704 shares (the "Shares") of 8% cumulative convertible exchangeable preferred stock, par value $0.01 per share, of Marvel Enterprises, Inc., a Delaware corporation (the "Company"). You are members of the Investor Group under the Stockholders' Agreement dated as of October 1, 1998 by and among the Company, Avi Arad, you, the Perlmutter Entities, Chase, Morgan Stanley, and Whippoorwill (the "Stockholders' Agreement"). Capitalized terms not defined in this letter have the same meanings here as they do in the Stockholders' Agreement. You have informed us that, effective upon the Sellers' sale to us of the Shares, each of you, as Dickstein Entities, and Mark Dickstein, as Dickstein Designator, waive your rights under the Stockholders' Agreement to have a Dickstein Designee nominated and/or elected as a Director. You have also informed us that, effective upon the Sellers' sale to us of the Shares, you relinquish all your other rights under the Stockholders' Agreement. Mark Dickstein, as Dickstein Designator, agrees that if any part of the foregoing waiver and relinquishment is ineffective, then he shall, at any time when permitted to make designations under the Stockholders' Agreement, designate an individual named by the Investor Group Designator as the Dickstein Designee. We are relying, in purchasing the Shares from the Sellers, on the waiver and relinquishment referred to above. With respect to those of you who are Sellers, we are also relying upon your acknowledgment of the following: (i) that, until Mark Dickstein's resignation as a member of the Company's Board of Directors, you had, or had access to, information about the Company as a result of Mr. Dickstein's service on the Company's Board of Directors and otherwise that was the equivalent of the information about the Company which we have, or to which we have access, as a result of Isaac Perlmutter's service on the Company's Board of Directors and otherwise; (ii) that your decision to sell 888086.4 us the Shares has been made without reliance on, or solicitation by, us, our representatives or the Company; (iii) that the price at which you intend to sell us the Shares is a price at which you would sell the shares, on the same terms, to any willing buyer at this time (regardless of whether we believe the shares are worth more than the sales price); and (iv) that, except for the payment of the purchase price for the Shares, we will have no liability to you arising from your sale to us of the Shares. We acknowledge that you will have no liability to us arising from the Sellers' sale to us of the Shares, other than your obligations under this letter and the Sellers' obligation to deliver the Shares to us free and clear of any encumbrances or adverse claims. Please indicate your agreement to the foregoing by signing below. Very truly yours, CLASSIC HEROES, INC. By: /s/ Isaac Perlmutter ----------------------------------- Name: Isaac Perlmutter Title: President BIOBRIGHT CORPORATION By: /s/ Isaac Perlmutter ----------------------------------- Name: Isaac Perlmutter Title: President ISAAC PERLMUTTER T.A. By: /s/ Isaac Perlmutter ----------------------------------- Name: Isaac Perlmutter Title: Trustee 888086.4 -2- AGREED: /s/ Mark Dickstein - ----------------------------------- Mark Dickstein, in his individual capacity and as the Dickstein Designator DICKSTEIN & CO., L.P. By: Dickstein Partners, L.P. By: Dickstein Partners Inc. By: /s/ Alan S. Cooper ----------------------------------- Name: Alan S. Cooper Title: Vice President DICKSTEIN FOCUS FUND L.P. By: Dickstein Partners, L.P. By: Dickstein Partners Inc. By: /s/ Alan S. Cooper ----------------------------------- Name: Alan S. Cooper Title: Vice President DICKSTEIN INTERNATIONAL LIMITED By: Dickstein Partners Inc. By: /s/ Alan S. Cooper ----------------------------------- Name: Alan S. Cooper Title: Vice President ELYSSA DICKSTEIN, JEFFREY SCHWARZ AND ALAN COOPER AS TRUSTEES U/T/A/D 12/27/88, MARK DICKSTEIN, GRANTOR By: /s/ Alan S. Cooper ----------------------------------- Alan S. Cooper Trustee MARK DICKSTEIN AND ELYSSA DICKSTEIN, AS TRUSTEES OF THE MARK AND ELYSSA DICKSTEIN FOUNDATION By: /s/ Mark Dickstein ----------------------------------- Mark Dickstein Trustee 888086.4 -3- -----END PRIVACY-ENHANCED MESSAGE-----